Bio-Rad Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Bio-Rad Labs (BIO) Tops Q2 EPS by 39c
July 30, 2020 4:25 PM EDTBio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.61, $0.39 better than the analyst estimate of $1.22. Revenue for the quarter came in at $536.9 million versus the consensus estimate of $517.05 million.
2020 Financial Outlook
Given the uncertainties regarding the duration and impact of the COVID-19 pandemic, the company... More
